Answers are grounded in this paper and cite their sources.
Microbial carbohydrate-active enzymes often contain non-catalytic carbohydrate-binding modules, which enhance the activity of the catalytic domain by proximity, targeting, or disruptive effects. We have previously biochemically characterized a GH29 α-L-fucosidase from Streptosporangium roseum, demonstrated that its C-terminal F-type lectin domain (FLD) improves the enzyme activity of its tandem N-terminal α-L-fucosidase domain towards fucooligosaccharides, and proposed a “bind and jump” model to explain this FLD-driven improvement of α-L-fucosidase activity. Here, we have explored the use of non-native, non-FLD carbohydrate-binding domains to similarly enhance the enzymatic activity of the α-L-fucosidase domain. We employed three carbohydrate-binding domains (MG1D1, MN3α, and MU1α) that we previously identified from the gut microbial metagenome by functional screening, and fused them to the N-terminus of the S. roseum α-L-fucosidase domain. The constructs showed activity on a synthetic substrate, 4-Methylumbelliferyl-α-L-fucopyranoside. However, when assaying these constructs on the natural fucosylated oligosaccharides, Lewis a tetrasaccharide and 2′-fucosyllactose, we did not observe a statistically significant improvement in the α-L-fucosidase activity of MN3α- Sr Fuc, MG1D1- Sr Fuc, or MU1α- Sr Fuc, compared to the Sr Fuc construct containing only the α-L-fucosidase domain. Our results indicate that the tandem positioning of these non-native, non-FLD carbohydrate-binding domains does not significantly improve the α-L-fucosidase activity of Sr Fuc towards these oligosaccharides. Additional chimeric constructs with domain organizations designed to closely mimic the wild-type protein Sr FucNaFLD, and further studies focused on the mechanistic basis of the FLD-mediated improvement of α-L-fucosidase activity, might help translate the strategy and design chimeric α-L-fucosidases with non-native, non-FLD carbohydrate-binding domains that exhibit improved α-L-fucosidase activity towards these oligosaccharides.
No takes yet. Share an insight, caveat, or question.
Shivangi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: